MENLO PARK, Calif., Sept. 12 /PRNewswire-FirstCall/ -- XTENT, Inc. today announced that Timothy D. Kahlenberg, Chief Financial Officer, will present at the 4th annual Merriman Curhan Ford & Co. Investor Summit on Monday, September 17, 2007 at 10:45 a.m. Pacific. This event will be held at the Mark Hopkins InterContinental Hotel in San Francisco. There will also be a webcast available at http://www.wsw.com/webcast/mcm7/xtnt/.
About XTENT
XTENT, Inc. is a medical device company focused on developing and commercializing innovative customizable drug eluting stent (DES) systems for the treatment of coronary artery disease (CAD). CAD is the most common form of cardiovascular disease and the number one cause of death in the United States and Europe. XTENT(R) Custom NX(R) DES Systems are designed to enable the treatment of single lesions, long lesions and multiple lesions of varying lengths and diameters, in one or more arteries with a single device. Note: XTENT(R) Custom NX(R) DES Systems have not been approved for sale by any regulatory authority.
XTENT, Inc.CONTACT: Investors, Tim Kahlenberg, Chief Financial Officer of XTENT,Inc., +1-650-475-9400, tkahlenberg@xtentinc.com; or Media Relations, AimeeCorso, +1-310-780-2661, acorso@weisscommpartners.com, or Julio Cantre,+1-415-946-1055, jcantre@weisscommpartners.com, both for XTENT, Inc.
Web site: http://www.xtentinc.com/
